Diabetes is a growing epidemic, and the US market for diabetes care devices -
including glucose monitoring devices and insulin delivery devices - will
experience strong growth through 2017 as a result.
RESEARCH METHODOLOGY
This report uses a number of methodologies to gather and present data and
analysis. At the outset, a large survey of secondary sources is conducted.
These sources act as the basis for the primary research stage, which builds
and enhances the quantitative and qualitative attributes of the early research.
Secondary sources include
government publications, such as documentation from securities
commissions, health care and statistical agencies, and regulatory and patent
authorities;
material provided by medical technology companies, including annual
reports, product brochures, and corporate profiles;
internal databases and reports, including previous reports on similar or
related topics; and
general Internet searches, medical literature, and newspaper and magazine
searches to identify various centers of specialization and articles that might
provide leads for primary research.
The secondary research stage builds the foundation for the primary research.
The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine its
utility based on the specific requirements of this report. Each piece of
information is either discarded or marked as high- or low-priority and then
organized appropriately determined by the structure and sectioning of the
report.
Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various market segments. These
assumptions are then used to determine hypotheses using both inductive and
deductive approaches. On the quantitative front, these hypotheses result in
full historical and projected market data sets (market sizes - unit sales,
ASPs, and revenues - as well as market shares).
Step 3: At this stage, the research is in position for its most
important primary phase - expert interviews. Throughout the secondary research
phase, industry and medical experts are identified. These experts are then
contacted by telephone and asked to participate in interviews on recent trends
and developments in the industry. Interviews are either conducted at the time
of the initial call or scheduled at the convenience of the expert. Interview
questions are tailored to the expertise of each particular interviewee,
although in most cases, the most important questions are asked of all experts.
The questions are largely based on the assumptions and hypotheses developed in
Step 2, which are then augmented, discarded, or adjusted based on the views
and positions put forth. Attempts are made, whenever possible, to cross-check
the views of various experts against each other and to reach positions of
consensus on issues and market numbers.
In some cases, a sample of relevant physicians is surveyed or interviewed.
Physicians are asked to comment on various issues and trends, both in their
own practice and in the overall market. The responses provided are then used
to strengthen or augment the assumptions and hypotheses developed during the
primary research phase.
Step 4: The final stage of primary research involves individual and
group analysis by Millennium Research Group. All research results are assessed
and cross-checked thoroughly to determine their validity, relevance, and
weight. From this process, qualitative conclusions are reached and data points
finalized.
MARKETRACK METHODOLOGY
Millennium Research Group's Marketrack methodology involves recruiting
hospital personnel responsible for the management of medical equipment and
procedures to participate by providing procedure volumes, device usage data,
and brand-level pricing information on an ongoing basis. Hospital respondents
include facility managers, nurses, administrators, and physicians. Information
is generally collected on a quarterly basis and includes, but is not limited
to, numbers and types of procedures performed and devices used.
FORECAST METHODOLOGY
In addition to the research methodology outlined above, the following
"bottom-up" methodology is used to develop forecast assumptions for the report.
A comprehensive breakdown of various procedures and device unit sales is
prepared using data from several sources, including professional associations,
government statistics, and private research/media sources. Industry experts
and practitioners are consulted to ensure accuracy and verify observed trends.
As a cross-check, total industry revenues available through annual reports and
other sources are compared against modeled industry revenues.
Using the best estimates of industry experts, practitioners, private
research/media sources, and inhouse experts, year-by-year growth rates and
ASPs are applied individually to each subcategory to derive forecasts. These
estimates are cross-checked by industry experts (marketing managers, product
managers, company executives, etc.) and further refined.
Overall findings are compared against market and procedure forecasts published
by other sources to ensure reasonable estimates.
Companies Mentionned:
Abbott Laboratories
Advocate Meters
AgaMatrix
Allison Medical
ARKRAY
Bayer HealthCare
BD
BIONIME
Cellnovo
CeQur
Covidien
Dexcom
Echo Therapeutics
Eli Lilly
GlySens
Insulet
Invacare
Johnson & Johnson
Medtronic
Nipro
Nova Biomedical
Novo Nordisk
Owen Mumford
Pic Solution
PPS Healthcare
ReliaMed
Roche
Sanofi
Senseonics
Simple Diagnostics
SOOIL Development
Tandem Diabetes Care
Terumo
UltiMed
USDiagnostics
Valeritas
VitalCare
Walgreens
Walmart
Table of Contents
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
1. COUNTRY OVERVIEWS
1.1. Demographics and Economy
1.2. Health Care System
1.3. Regulatory Environment
2. CLINICAL LANDSCAPE
2.1. Background
2.1.1. Diabetes
2.2. Procedure Descriptions
2.2.1. Multiple Daily Injection Therapy
2.2.2. Insulin Pump Therapy
2.3. Guidelines and Diagnosis Patterns
3. PRODUCTS
3.1. Product Descriptions
3.1.1. Glucose Monitoring Devices
3.1.1.1. Self-Monitoring Blood Glucose Devices
3.1.1.1.1. Functions
3.1.1.2. Continuous Glucose Monitoring Devices
3.1.1.2.1. Functions
3.1.2. Insulin Delivery Devices
3.1.2.1. Multiple Daily Injection Devices
3.1.2.1.1. Insulin Syringes
3.1.2.1.1.1. Functions
3.1.2.1.2. Insulin Pens
3.1.2.1.2.1. Functions
3.1.2.1.2.2. Differentiating Features
3.1.2.2. Insulin Pumps
3.1.2.2.1. Functions
3.1.2.2.2. Differentiating Features
3.2. Future Technologies
4. CLINICAL TRIALS
4.1. Completed Clinical Trials
4.2. Ongoing Clinical Trials
5. DIABETES CARE DEVICE MARKET
5.1. Market Snapshot
5.2. Detailed Market Analysis
5.3. Competitive Snapshot
5.4. Detailed Competitive Landscape
5.5. Market Shares
5.6. Most Promising Emerging Products
6. GLUCOSE MONITORING DEVICE MARKET
6.1. Market Snapshot
6.2. Detailed Market Analysis
6.2.1. Self-Monitoring Blood Glucose Devices
6.2.2. Continuous Glucose Monitoring Devices
6.3. Competitive Snapshot
6.4. Detailed Competitive Landscape
6.4.1. Self-Monitoring Blood Glucose Devices
6.4.2. Continuous Glucose Monitoring Devices
6.5. Market Shares
7. INSULIN DELIVERY DEVICE MARKET
7.1. Market Snapshot
7.2. Detailed Market Analysis
7.2.1. Multiple Daily Injection Devices
7.2.1.1. Insulin Syringes
7.2.1.2. Insulin Pens
7.2.2. Insulin Pumps
7.2.2.1. Conventional Pumps and Accessories
7.2.2.2. Patch Pumps
7.3. Competitive Snapshot
7.4. Detailed Competitive Landscape
7.5. Market Shares
APPENDIX: METHODOLOGY
APPENDIX: ACRONYMS AND INITIALISMS
APPENDIX: BIBLIOGRAPHY
LIST OF FIGURES AND TABLES
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
Figure 1: Diabetes Care Device Market, by Product Type, US (USD), 2011 -
2017
Table 1: Diabetes Care Device Market Landscape, US (USD), 2012 and 2017
Table 2: Diabetes Care Device Market Leaders, by Product Type and Revenue,
US, 2012
Table 3: Companies Mentioned
Table 4: Factors Impacting the Diabetes Care Device Market, by Product
Type, US, 2012 - 2017
Table 5: Expected Key Events in the Diabetes Care Device Market, US, 2013
- 2017
Table 6: Diabetes Care Devices Covered, US
1. COUNTRY OVERVIEWS
Table 7: Key Health and Economic Indicators, US
2. CLINICAL LANDSCAPE
3. PRODUCTS
Table 8: Advantages and Disadvantages of Insulin Delivery Devices, by
Product Type
Table 9: Advantages and Disadvantages of MDI Devices, by Product Type
Table 10: Advantages and Disadvantages of Insulin Pumps, by Product Type
4. CLINICAL TRIALS
Table 11: Summary of STAR3
Table 12: Summary of Randomized Study of Real-Time Continuous Glucose
Monitors (RT-CGM) in the Management of Type 1 Diabetes
Table 13: Summary of ASPIRE
Table 14: Summary of Three-day, In-clinic Evaluation of the BD 2nd
Generation Continuous Glucose Sensor Device in Type 1 Diabetics
Table 15: Summary of Use of the FreeStyle Navigator Continuous Glucose
Monitoring System to Enhance Education and Glycaemic Control
Table 16: Summary of Evaluation of Blood Glucose Monitoring Systems
5. DIABETES CARE DEVICE MARKET
Figure 2: Diabetes Care Device Market, by Product Type, US (USD), 2011 -
2017
Table 17: Factors Impacting the Diabetes Care Device Market, by Product
Type, US, 2012 - 2017
